AXA Apex Select InvestLife Plan Notices

2022
2021
2020
[Pictet] Relocation and conversion of the Depositary Bank of Pictet and the Reference Funds
PDF 214.7 KB
[Pictet] Addition of example of fees that may be charged to the Reference Funds
PDF 196.9 KB
[Schroder] Change to investment policies of the Reference Fund
PDF 199.9 KB
[Franklin Templeton] Creation of the restricted share classes and reopening for dealing of the non-restricted part of the Reference Fund’s portfolio
PDF 586.6 KB
[Janus Henderson] Appointment of Sub-Investment Adviser of the Reference Fund
PDF 208.6 KB
[Schroder] Change in delegation arrangement
PDF 239.9 KB
[Janus Henderson] Rename of the Management Company of Reference Fund
PDF 271 KB
[Fidelity] Name change of the investment option
PDF 326.9 KB
[Janus Henderson] Fund Termination_Apex_Select
PDF 369.8 KB
[Schroder] changes to the investment policy and the chinese fund name_ApexSelect
PDF 315.6 KB
Temporary suspension of net asset value calculation and dealing in units of certain investment options
PDF 96.8 KB

Important Notes

  1. Investment involves risks, including fluctuation of market price of investment. The value of the investments and their yield may go down as well as up as a consequence of the general nature of various investments. Past performance is not indicative of future performance. It is important for you to know your risk tolerance level and the level of risks associated with your investment before making any investment decisions. Please refer to the respective Principal Brochures of different investment-linked insurance plans for details including the risk factors.
  2. You should not purchase these plans unless you understand them and it has been explained to you how they are suitable to you. The final decision is yours
  3. Please do not invest based on the information in this website only.
  4. You are strongly recommended to read the Principal Brochures of the investment-linked insurance plans (including the Product Brochures, the Investment Options Leaflets and the Product Key Facts Statements) and the respective offering documents of the reference funds carefully, which are made available by the Company.